NPI: 1720645468 · MOBILE, AL 36617 · Emergency Medicine Physician · NPI assigned 05/28/2019
Authorized official BAILEY, GLEN controls 20+ related entities in our dataset. Read more
| Authorized Official | BAILEY, GLEN (CEO) |
| NPI Enumeration Date | 05/28/2019 |
Other providers sharing the same authorized official: BAILEY, GLEN
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 4,813 | $163K |
| 2021 | 6,404 | $282K |
| 2022 | 7,102 | $409K |
| 2023 | 7,847 | $459K |
| 2024 | 10,052 | $672K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,585 | 4,315 | $361K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,316 | 2,217 | $315K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 2,637 | 2,516 | $202K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,260 | 3,045 | $164K |
| 99215 | Prolong outpt/office vis | 1,118 | 978 | $134K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1,085 | 1,057 | $125K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 577 | 543 | $115K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 911 | 890 | $88K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,278 | 1,235 | $51K |
| 99239 | Hospital discharge day management, more than 30 minutes | 424 | 403 | $36K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 671 | 210 | $35K |
| 74018 | 1,356 | 692 | $32K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 402 | 395 | $26K |
| 99238 | Hospital discharge day management, 30 minutes or less | 303 | 294 | $21K |
| 71046 | Radiologic examination, chest; 2 views | 787 | 728 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 435 | 428 | $20K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 271 | 266 | $20K |
| 90461 | 430 | 422 | $19K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 91 | 89 | $17K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 271 | 262 | $16K |
| 99233 | Prolong inpt eval add15 m | 167 | 65 | $15K |
| 99460 | 112 | 112 | $14K | |
| 90651 | 55 | 55 | $13K | |
| 99222 | Initial hospital care, per day, moderate complexity | 129 | 117 | $12K |
| 71045 | Radiologic examination, chest; single view | 2,641 | 1,506 | $11K |
| 99223 | Prolong inpt eval add15 m | 79 | 68 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 139 | 128 | $9K |
| 99243 | 99 | 97 | $9K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4,925 | 3,642 | $8K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 94 | 91 | $7K |
| 90734 | 43 | 43 | $6K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 80 | 77 | $6K |
| 90686 | 301 | 296 | $6K | |
| 90670 | 25 | 25 | $5K | |
| 93000 | 146 | 144 | $4K | |
| 93325 | 117 | 94 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 173 | 167 | $4K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 12 | 12 | $3K |
| 92551 | 177 | 176 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 316 | 302 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 137 | 131 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 146 | 139 | $3K |
| 99462 | 34 | 24 | $2K | |
| 99177 | 230 | 217 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | 367 | 236 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 57 | 56 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 31 | 30 | $909.41 |
| 82947 | 163 | 154 | $609.52 | |
| 99173 | 121 | 118 | $546.29 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16 | 16 | $496.32 |
| 93321 | 14 | 14 | $490.04 | |
| 90633 | 12 | 12 | $415.14 | |
| 90656 | 15 | 15 | $335.25 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 18 | 15 | $189.04 |
| 87807 | 12 | 12 | $133.44 | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 33 | 28 | $107.14 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 19 | 14 | $97.84 |
| 96160 | 33 | 28 | $32.25 | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 632 | 632 | $0.00 |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 318 | 199 | $0.00 |
| 99024 | 255 | 174 | $0.00 | |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | 50 | 37 | $0.00 |
| 99441 | 12 | 12 | $0.00 | |
| 90961 | 12 | 12 | $0.00 | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 48 | 14 | $0.00 |
| 99001 | 40 | 39 | $0.00 | |
| G9321 | Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study | 111 | 73 | $0.00 |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 219 | 161 | $0.00 |
| 90966 | 25 | 25 | $0.00 |